EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites

Divya Bezwada, James Brugarolas

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci170195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Divya Bezwada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center Research Institute. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansFumarate HydrataseImmunohistochemistryBiomarkers, Tumor

Substanzen

Fumarate HydrataseBiomarkers, Tumor

Autor:innen und Institutionen

  • Children's Medical Center Research Institute.
  • Kidney Cancer Program, Simmons Comprehensive Cancer Center, and.
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS

Zitieren

APA

Bezwada, D., & Brugarolas, J. (2023). Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites. Journal of Clinical Investigation. https://doi.org/10.1172/jci170195

Vancouver

Bezwada D, Brugarolas J. Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites. Journal of Clinical Investigation. 2023. doi:10.1172/jci170195

BibTeX
@article{Bezwada2023,
  author = {Bezwada, Divya and Brugarolas, James},
  title = {Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci170195}
}
Kostenlos starten →